Higher concentrations of TGF-β1 in the gastric adenocarcinoma tissue were linked with shorter patient survival, perhaps due to the patient-derived factors, i.e. higher body mass index (BMI) [16] which is associated with increased levels of adipose tissue-derived inflammatory factors and increased levels of adipose tissue-derived TGF-β1 and PAI1 [17]. The gene discussed is TGFB1; the disease is gastric adenocarcinoma.